StonvexLoading…
StonvexStonvexStonvexCore line items from EBS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2020 2020-12-31 |
|---|---|---|---|---|
Revenue | $742.90M | $1.04B | $1.05B | $1.56B |
Operating Income | $100.10M | $-108.70M | $-726.40M | $438.50M |
Net Income | $52.60M | $-190.60M | $-760.50M | $305.80M |
EPS (Diluted) | $0.93 | $-3.60 | $-14.85 | $5.68 |
Total Assets | $1.32B | $1.39B | $1.82B | $2.88B |
Total Liabilities | $796.00M | $906.90M | $1.17B | $1.44B |
Cash & Equivalents | $205.40M | $99.50M | $111.70M | $621.30M |
Free Cash Flow OCF − CapEx | $156.80M | $35.80M | $-257.90M | $395.00M |
Shares Outstanding | 52.10M | 54.30M | 52.20M | 53.10M |